May-Kin Ho, Ph.D.

Maykin Ho, Ph.D., is a retired Partner of Goldman Sachs & Co. where she spent 24 years, most recently as an Advisory Director for Global Healthcare Investment Banking.  She serves on the boards of directors for Agios Pharmaceuticals, Parexel International, and The Aaron Diamond AIDS Research Center, an affiliate of Rockefeller University.  She is also a venture partner of Qiming Venture Partners.  

Prior to joining Goldman Sachs, Maykin held senior management positions in research, marketing and business development at Dupont-Merck Pharmaceuticals and Dupont De Nemours & Company.  

Maykin was a biotechnology analyst and co-head of U.S. Healthcare for Global Investment Research.  She was ranked the First or Second Team in Biotechnology by Institutional Investor and Greenwich Associates for over 10 years. She has also received numerous awards from The Wall Street Journal and Financial Times.  Maykin has served on the Investment Committee of the Society for Neuroscience as well as the Advisory Council of the Department of Biological Chemistry at Harvard Medical School.

Maykin was a postdoctoral fellow with Timothy Springer at Harvard Medical School after earning a Ph.D. in Microbiology and Immunology from the State University of New York, Downstate Medical Center.  She is also a graduate of the Advanced Management Program of the Fuqua School of Business at Duke University.